RIO DE JANEIRO, BRAZIL - Cuba's Finlay Vaccine Institute (IFV) reported Thursday the combination of two doses of its candidate vaccine Soberana 02 with a booster dose of Soberana Plus had shown 91.2% efficacy against SARS-CoV-2, which causes Covid-19.
Soberana 02 and Soberana Plus - developed by the IFV - are two of the five vaccine projects against the coronavirus being investigated by Cuban scientific institutions.
Read also: Check out our coverage on Cuba
Preliminary analyses of the third and last phase of clinical trials . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here